Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kashpur, N"'
Publikováno v:
Anali Mečnikìvsʹkogo Institutu, Iss 2, Pp 94-96 (2020)
Annals of Mechnikov's Institute; № 2 (2020); 94-96
Annals of Mechnikov's Institute; № 2 (2020); 94-96
For more than a century, the name of I.I. Mechnikov has been shining in the constellation of the names of outstanding scientists, whose works laid the foundations for the formation of a scientific worldview of all living things: from a small microorg
Autor:
Volyanskiy, A, Pogorila, M, Romanova, E, Davidova, T, Martynov, A, Igumnova, N, Sidorenko, T, Yukhimenko, V, Peremot, S, Smilianska, M, Kashpur, N
Publikováno v:
Annals of Mechnikov's Institute; № 3 (2014); 13-18
Introduction Due to the high mutagenicity that distinguishes influenza A virus, there are viruses of this type of new antigenic properties, the prevention of which the immune system has no immunological memory. It is therefore important to find new w
Publikováno v:
Anali Mečnikìvsʹkogo Institutu, Vol 1, Pp 48-55 (2016)
According to the research of the last decade, there has been growth in the noncoronary disease infarction, increased their share among the causes temporary or persistent disability, disability and deaths. Among others myocarditis, which constitute 11
Autor:
Peremot, S. D., Volianskyi, A. Y., Smilianska, M. V., Kashpur, N. V., Klysa, O.O., Klysa, T. L.
Publikováno v:
Anali Mečnikìvsʹkogo Institutu, Iss 3, Pp 15-18 (2018)
Introduction. The concept of "idiopathic ventricular arrhythmias" (IVA), i.e. arrhythmias that have arisen in the absence of structural disorders of the heart, is becoming more and more conventional. As for today, "idiopathic arrhythmia" is the main
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4ca9539c817a91719e2ddbe1076328
Publikováno v:
Anali Mečnikìvsʹkogo Institutu, Iss 3, Pp 56-61 (2017)
The need for an individual approach in the choice of means for the prevention of complications in inflammatory processes in cardiomyocytes, the course of which unfolds against a persistent viral infection, dictates the need to determine the general m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f43ddb636efb9049d4f5c2b4a64cf7b
Publikováno v:
Anali Mečnikìvsʹkogo Institutu, Iss 4, Pp 40-45 (2016)
Viral myocarditis is a heterogeneous group of diseases not only by etiologic factors, which belong to different families of Vira kingdom, but is also characterized by a unique mechanism of inflammatory process and cytokine levels specific for each of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::648c11f9da2f1df561051a92e8b08d40
Publikováno v:
Український біофармацевтичний журнал; № 1(42) (2016): Український біофармацевтичний журнал; 58-62
Ukraïns’kij bìofarmacevtičnij žurnal; № 1(42) (2016): Ukraïns’kij bìofarmacevtičnij žurnal; 58-62
Украинский биофармацевтический журнал; № 1(42) (2016): Украинский биофармацевтический журнал; 58-62
Ukraïns’kij bìofarmacevtičnij žurnal; № 1(42) (2016): Ukraïns’kij bìofarmacevtičnij žurnal; 58-62
Украинский биофармацевтический журнал; № 1(42) (2016): Украинский биофармацевтический журнал; 58-62
The screening of antibacterial activity of two complexes of biologically active substances from Veronica longifolia ‘Blaubart’ herb, obtained successively by means of chloroform and ethyl acetate were conducted respect to gram-negative (Escherich
Autor:
Kashpur, N. V., Yurchenko, N. S., Ilyina, T. V., Kovalyova, A. M., Goryacha, O. V., Smilyanska, M. V., Peremot, S. D.
Publikováno v:
Clinical pharmacy; Vol. 19 No. 1 (2015); 56-58
Клиническая фармация; Том 19 № 1 (2015); 56-58
Клінічна фармація; Том 19 № 1 (2015); 56-58
Клиническая фармация; Том 19 № 1 (2015); 56-58
Клінічна фармація; Том 19 № 1 (2015); 56-58
The research presents results of in vitro studies of the effect of dry extracts of Asperula odorata and Asperula humifusa on the functional activity of macrophages and their hematogenous precursors. It has been found that the extracts studied reveal
Publikováno v:
Клінічна фармація; Том 18, № 4 (2014): Клінічна фармація; 49-51
Klìnìčna farmacìâ; Том 18, № 4 (2014): Klìnìčna farmacìâ; 49-51
Клиническая фармация; Том 18, № 4 (2014): Клиническая фармация; 49-51
Klìnìčna farmacìâ; Том 18, № 4 (2014): Klìnìčna farmacìâ; 49-51
Клиническая фармация; Том 18, № 4 (2014): Клиническая фармация; 49-51
Вперше встановлено антибактеріальну активність ліпофільних комплексів біологічно активних речовин (БАР) видів роду підмаренник флори
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.